Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metroglas AG was a Swiss-based manufacturer specializing in the development and production of high-precision glass sensors and electrodes, primarily for pH measurement and titration. The company's products were widely utilized in laboratory settings within the pharmaceutical, biotechnology, and chemical industries to ensure accurate analytical results during research and quality control processes. In 2002, Metroglas was acquired by Metrohm AG, a leading global provider of precision instruments for chemical analysis. Following the acquisition, Metroglas's expertise and manufacturing capabilities were integrated into Metrohm's sensor division, where they continue to support the life sciences sector. The brand is recognized for its specialized glass-blowing techniques and electrochemical sensor technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metroglas.